Mackay Shields LLC’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-104,484
Closed -$6.01M 357
2022
Q1
$6.01M Sell
104,484
-4,373
-4% -$224K 0.05% 313
2021
Q4
$5.15M Sell
108,857
-3,842
-3% -$175K 0.04% 364
2021
Q3
$4.74M Sell
112,699
-3,262
-3% -$141K 0.04% 348
2021
Q2
$5.14M Sell
115,961
-44,210
-28% -$2.04M 0.05% 333
2021
Q1
$7.47M Buy
160,171
+35,555
+29% +$1.57M 0.05% 370
2020
Q4
$4.83M Sell
124,616
-1,622
-1% -$58K 0.03% 491
2020
Q3
$3.64M Sell
126,238
-33,373
-21% -$940K 0.02% 530
2020
Q2
$4.28M Sell
159,611
-5,435
-3% -$141K 0.03% 460
2020
Q1
$3.88M Buy
165,046
+6,222
+4% +$171K 0.04% 436
2019
Q4
$4.7M Sell
158,824
-9,586
-6% -$254K 0.03% 483
2019
Q3
$4.71M Sell
168,410
-4,999
-3% -$145K 0.03% 516
2019
Q2
$5.13M Buy
+173,409
New +$4.67M 0.04% 513

Other funds holding CTVA

Mackay Shields LLC's CTVA Position: Q2 2022 in Review

Mackay Shields LLC sold out of Corteva (CTVA) in Q2 2022, closing a stake of 104,484 shares — an estimated $6.01M sold.

Mackay Shields LLC first reported a position in CTVA in Q2 2019 and held it in 12 quarters. The position peaked at $7.47M in Q1 2021. 1,190 funds tracked by Wall St. Rank hold CTVA as of Q2 2022.

  • Mackay Shields LLC reported no remaining Corteva position as of Q2 2022 after selling out during the quarter.
  • Mackay Shields LLC sold 104,484 Corteva shares in Q2 2022, an estimated $6.01M.
  • Mackay Shields LLC first reported a position in Corteva in Q2 2019 and held it in 12 quarters.
  • Mackay Shields LLC's Corteva position peaked at $7.47M in Q1 2021.
  • 1,190 funds tracked by Wall St. Rank held Corteva as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.